KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other Operating Expenses: 2013-2015

Historic Other Operating Expenses for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Sep 2015 value amounting to $1.4 million.

  • Biocryst Pharmaceuticals' Other Operating Expenses was N/A to $1.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $122,000 for FY2014, which is 37.44% down from last year.
  • As of Q3 2015, Biocryst Pharmaceuticals' Other Operating Expenses stood at $1.4 million, which was up 205.66% from $442,000 recorded in Q2 2015.
  • Biocryst Pharmaceuticals' Other Operating Expenses' 5-year high stood at $1.4 million during Q3 2015, with a 5-year trough of $5,000 in Q2 2014.
  • In the last 3 years, Biocryst Pharmaceuticals' Other Operating Expenses had a median value of $74,000 in 2014 and averaged $260,500.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Other Operating Expenses slumped by 93.51% in 2014, and later skyrocketed by 8,740.00% in 2015.
  • Biocryst Pharmaceuticals' Other Operating Expenses (Quarterly) stood at $17,000 in 2013, then skyrocketed by 158.82% to $44,000 in 2014, then skyrocketed by 8,740.00% to $1.4 million in 2015.
  • Its Other Operating Expenses stands at $1.4 million for Q3 2015, versus $442,000 for Q2 2015 and $75,000 for Q1 2015.